{
    "code": "02022282",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022282",
    "time": "2021-08-27 03:09:18",
    "許可證字號": "衛署藥輸字第022282號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/08\/31",
    "發證日期": "87\/08\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202228202",
    "中文品名": "安美達錠１毫克",
    "英文品名": "ARIMIDEX TABLETS 1MG",
    "適應症": "治療停經後婦女晚期乳癌。其療效對於雌激素接受器陰性之病人尚未被證實，除非這些病人曾經對TAMOXIFEN有陽性反應。\r\n輔助治療停經後婦女且荷爾蒙接受器為陽性的早期侵犯性乳癌。\r\n輔助治療已使用tamoxifen 2-3年之停經後婦女且荷爾蒙接受器為陽性的早期乳癌。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "94\/08\/31",
    "主成分略述": "ANASTROZOLE",
    "限制項目": "02輸　入 53依本署七七公告事項八得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0516000  ASTRAZENECA PHARMACEUTICALS LP",
            "製造廠廠址": "587 OLD BALTIMORE PIKE,NEWARK, DE 19702, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FGB0053000  ASTRAZENECA UK LIMITED",
            "製造廠廠址": "SILK ROAD BUSINESS PARK,MACCLESFIELD,CHESHIRE,SK10 2NA",
            "製造廠公司地址": "ALDERLEY PARK MACCLESFIELD CHESHIRE SK 10 4TF",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "包裝"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004001800",
            "成分名稱": "ANASTROZOLE",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "雙凸膜衣錠",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "022282-Arimidex 1mg Tab-Blister-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022282&Seq=436&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "20210621-Arimidex Tab 1mg TPI-110-07-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022282&Seq=044&Type=9"
        },
        {
            "title": "022282-Arimidex-Tablet-1mg-foil-108-04-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022282&Seq=008&Type=8"
        },
        {
            "title": "022282-Arimidex-Tablet-1mg-carton-108-04-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022282&Seq=007&Type=8"
        },
        {
            "title": "022282-Arimidex-Tablet-1mg-foil-108-04-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022282&Seq=006&Type=8"
        },
        {
            "title": "022282-Arimidex-Tablet-1mg-carton-108-04-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022282&Seq=005&Type=8"
        }
    ]
}